# Atrium Therapeutics, Inc.: filings

RNA · Nasdaq · CIK 2093101 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/rna.md) · [Financials](/companies/rna/financials.md) · [Filings](/companies/rna/filings.md) · [Insiders](/companies/rna/insiders.md)

## Reports and events: 9 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 19, 3 11, 8-K 6, SCHEDULE 13G 3, 10-12B/A 2, 10-Q 2, S-8 2, SCHEDULE 13G/A 2, 10-12B 1, 8-K/A 1, CERT 1, SEC STAFF ACTION 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-09 | 06:17 ET | [8-K/A](/filings/0001193125-26-418417.md) | 8.01 Other events | 0001193125-26-418417 |
| 2026-10-08 | 06:52 ET | [8-K](/filings/0001193125-26-417402.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-417402 |
| 2026-08-13 | 16:51 ET | [10-Q](/filings/0001193125-26-349488.md) | Quarterly report, period 2026-06-30 | 0001193125-26-349488 |
| 2026-08-13 | 16:50 ET | [8-K](/filings/0001193125-26-349482.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-349482 |
| 2026-07-14 | 17:14 ET | [8-K](/filings/0001193125-26-303393.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-303393 |
| 2026-05-14 | 16:51 ET | [10-Q](/filings/0001193125-26-224243.md) | Quarterly report, period 2026-03-31 | 0001193125-26-224243 |
| 2026-05-14 | 16:50 ET | [8-K](/filings/0001193125-26-224238.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-224238 |
| 2026-02-27 | 17:22 ET | [8-K](/filings/0001193125-26-083227.md) | 1.01 Entry into a material agreement; 5.01 Change in control; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-26-083227 |
| 2026-02-26 | 16:50 ET | [8-K](/filings/0001193125-26-077105.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-077105 |

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 27, 2026, 08:57 ET. No prices; not investment advice.